Pharma second one fourth net reduction decreases to $1.

Pharma second one fourth net reduction decreases to $1.9 million A.P. Pharma, Inc. , a specialty pharmaceutical company, reported financial results because of its second quarter ended June 30 today, 2011 and highlighted its recent corporate improvement.P. Pharma closed an exclusive placement financing for $1.5 million in convertible notes, with an additional $3.0 million available to the Company at the investors’ discretion within 2 yrs of the closing date. On 29 June, 2011, the business announced it entered right into a definitive contract for a $24.0 million private positioning of common stock and warrants.Albain stated. These results are changing how we manage young females with breast malignancy. The Stage 3 multicenter trial included premenopausal women younger than 50 who acquired specific types of early-stage breasts cancers . For this study, 257 patients were assigned to get regular chemotherapy or chemotherapy plus goserelin randomly. After two years, 22 % of women receiving standard chemotherapy had stopped menstruating or experienced elevated degrees of a hormone referred to as FSH, a sign of reduced estrogen egg and production supply.